Biomarker Applications for Nanotechnology and Imaging in Diabetes

Projektinformationen

UROSENSE

ID Finanzhilfevereinbarung: 286386

Abgeschlossenes Projekt

Startdatum 1 Januar 2012

Enddatum 31 Dezember 2015

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 2 482 306,00

EU-Beitrag € 2 482 306,00

Koordiniert durch

DUBLIN CITY UNIVERSITY
Ireland

Ziel

UroSense is a focussed research programme to generate new concepts from knowledge creation to knowledge transfer between innovative academic and dedicated industry partners utilising a systematic intersectoral secondment programme. The programme brings leading edge academic European LifeScience capacities of Diabetes research at Dublin City University, Ireland, together with the high-profile protein research center of University of Luxembourg to establish innovative biomarker utilisation. The nano-biotechnologies developed with established life science applications of Tethis S.p.A of Milano, Italy will be the SME partner to translate findings to microfluidic applications while GE Medical System of Sweden will integrate results to the recently established, robust molecular imaging technologies leading to novel diagnostics for the benefit of the diabetes patient. The Chinese partner is a leading biotech company in Guangzhou who will provide not only validation of results but also to develop access to the fastest growing global healthcare market benefiting both academic and industrial partners. All European partners are unequivocally in the leading edge in their own sectors sharing the vision of true impacts achieved with a new collaborative working model including efficient knowledge transfer and a shared clear scientific focus. Our consortium is particularly well balanced, focussed and well resourced to cover the value chain from discovery research to applications utilising novel intersectoral collaborations to expedite the utilisation process.

Wissenschaftliches Gebiet

• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• engineering and technology › nanotechnology
• medical and health sciences › clinical medicine › endocrinology › diabetes

Programm/Programme

• FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Thema/Themen

• FP7-PEOPLE-2011-IAPP - Marie Curie Action: "Industry-Academia Partnerships and Pathways"

Aufforderung zur Vorschlagseinreichung

FP7-PEOPLE-2011-IAPP
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

MC-IAPP - Industry-Academia Partnerships and Pathways (IAPP)

Koordinator

DUBLIN CITY UNIVERSITY

Kontakt Verwaltung

Dermot Diamond (Prof.)

• EU-Beitrag: € 946 883,00
• Adresse: Glasnevin ; 9 Dublin ; Irland
• Region: Ireland › Eastern and Midland › Dublin
• Aktivitätstyp: Higher or Secondary Education Establishments
• Gesamtkosten: Keine Daten

Beteiligte (5)

HELSINGIN YLIOPISTO

Finnland

Kontakt Verwaltung

Katariina Vainio-Mattila (Ms.)

• EU-Beitrag: € 466 757,00
• Adresse: YLIOPISTONKATU 3 ; 00014 Helsingin Yliopisto
• Region: Manner-Suomi › Helsinki-Uusimaa › Helsinki-Uusimaa
• Aktivitätstyp: Higher or Secondary Education Establishments
• Gesamtkosten: Keine Daten

GEMS PET SYSTEMS AKTIEBOLAG

Beteiligung beendet

Schweden

Kontakt Verwaltung

Bengt Nielsen (Dr.)

• EU-Beitrag: Keine Daten
• Adresse: HUSBYBORG ; 752 28 Uppsala
• Region: Östra Sverige › Östra Mellansverige › Uppsala län
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: Keine Daten

TETHIS SPA

Italien

Kontakt Verwaltung

Massimo Gatelli (Mr.)

• EU-Beitrag: € 644 531,00
• Adresse: VIA OLGIATI FRANCESCO 5 ; 20143 MILANO
• Region: Nord-Ovest › Lombardia › Milano
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: Keine Daten

GUANGZHOU KONCEN BIOSCIENCE CO LTD

China

Kontakt Verwaltung

Hequn Zou (Prof.)

• EU-Beitrag: € 424 135,00
• Adresse: SHENZHOU ROAD ACADEMIC CITY 8 ; 501660 GUANGZHOU
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: Keine Daten

LUXEMBOURG INSTITUTE OF HEALTH

Beteiligung beendet

Luxemburg

Kontakt Verwaltung

Bruno Domon (Prof.)

• EU-Beitrag: Keine Daten
• Adresse: 1A RUE RUE THOMAS EDISON ; 1445 Strassen
• Region: Luxembourg › Luxembourg › Luxembourg
• Aktivitätstyp: Research Organisations
• Gesamtkosten: Keine Daten